Yes, absolutely. One of the roles of international organizations is, in fact, to develop what are called target product profiles. What is the ideal profile of the vaccine that would be deployed around the world? In designing the ideal set of parameters that we would want a Canadian vaccine to have, it's absolutely essential that we and any other public health organization take that into consideration.
Indeed, at the table are representatives of countries that are going to potentially be particularly disproportionately impacted by this.
We know from other vaccines that the way in which they're developed is important. Whether it's injectable or administered with a dropper, at what temperature it needs to be stored, how long it can be out of the fridge, how many doses are in a vial and all of these things have to be included in the design and the development of vaccines at the early stage. That is absolutely essential for making sure we have a vaccine that is well adapted for global use so that it has the maximum potential impact and efficacy.
What you're describing, I would say, is a good example of that.